nanoComposix Expands Capabilities to Include Drug Manufacturing

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN DIEGO, June 11, 2019 /PRNewswire/ — nanoComposix, a nanotechnology development and contract manufacturing company, recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.  NanoComposix has been manufacturing nanomaterials for biotech clients under cGMPs (QSR, 21 CFR 820) since 2017. The facility includes a qualified ISO 8 cleanroom dedicated to cGMP manufacture of nanomaterial-based medical devices and drugs. As a contract manufacturing organization, the capability of manufacturing drugs in-house ensures nanoComposix’ growing number of clients have the flexibility to utilize one vendor throughout the product life cycle. 

nanoComposixnanoComposix

Founder & President Dr. Steve Oldenburg said: “This opens up a new set of capabilities for our clients and allows us to align with our long-term corporate goal of supplying nanotechnology enabled products from concept through commercialization.”

About nanoComposix

Since 2004, nanoComposix has provided development, fabrication, processing and scale-up to accelerate the commercialization of nanomaterial in several applications that include in-vitro diagnostics, therapeutics, devices, plasmonic, and preclinical drugs.  NanoComposix is focused on the development and scale up of cGMP manufacture of colloidal nanomaterials for its customers.

For more information about nanoComposix, please visit nanocomposix.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nanocomposix-expands-capabilities-to-include-drug-manufacturing-300865576.html

SOURCE nanoComposix

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare
AddThis Website Tools
Staff

Recent Posts

CareOregon and Health Share of Oregon Notify Members of Privacy Incident

PORTLAND, Ore., June 3, 2025 /PRNewswire/ -- CareOregon and Health Share of Oregon are notifying…

1 hour ago

CareOregon Notifies Members of Privacy Incident

PORTLAND, Ore., June 3, 2025 /PRNewswire/ -- CareOregon, Jackson Care Connect and Columbia Pacific CCO are…

1 hour ago

Tixel i® Demonstrates Sustained Improvements in Dry Eye Symptoms

Recent Publication Reports Durable Results and Patient Satisfaction KNOXVILLE, Tenn., June 3, 2025 /PRNewswire/ --…

7 hours ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

ST. PAUL, Minn., June 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will…

7 hours ago

BAILEY HOUSE ANNOUNCES THIRD ANNUAL ART HOUSE BENEFIT HONORING ARTIST DERRICK ADAMS

A CURATED ART AUCTION AND CELEBRATION OF ARTISTS IN SUPPORT OF HOUSING FOR NEW YORKERS…

7 hours ago

Net Health Acquires Limber Health

Investment Unites Two Leading Outcomes Platforms and Delivers Stronger Results for Enterprise Health Systems and…

7 hours ago